Your browser doesn't support javascript.
loading
Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women.
Rangel-Moreno, Karla; Gamboa-Loira, Brenda; López-Carrillo, Lizbeth; Cebrián, Mariano E.
Afiliação
  • Rangel-Moreno K; Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
  • Gamboa-Loira B; Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
  • López-Carrillo L; Instituto Nacional de Salud Pública, Av. Universidad 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
  • Cebrián ME; Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, Ciudad de México, C.P. 07360, Mexico. Electronic address: mcebrian@cinvestav.mx.
Environ Res ; 210: 112948, 2022 07.
Article em En | MEDLINE | ID: mdl-35189103
BACKGROUND: Experimental studies have shown the diabetogenic potential of inorganic arsenic (iAs); however, the epidemiological evidence is still inconclusive. This could be explained by differences in exposure, metabolism efficiency, nutritional and genetic factors. OBJECTIVE: To evaluate the association between type 2 diabetes mellitus (T2DM) prevalence with arsenic exposure and metabolism, considering one-carbon metabolism nutrient intake and arsenite methyltransferase (AS3MT) polymorphisms. METHODS: From healthy controls of a case control study for female breast cancer in northern Mexico, 227 self-reported diabetic women were age-matched with 454 non-diabetics. Participants were interviewed about dietary, sociodemographic and clinical characteristics. Urinary iAs metabolites were determined by HPLC-ICP-MS, methylation efficiency parameters were calculated, and AS3MT c.860 T > C and c.529-56G > C genotypes were determined. Unconditional logistic regression models were used to evaluate associations. RESULTS: Total arsenic in urine (TAs) ranged from 0.73 to 248.12 µg/L with a median of 10.48 µg/L. In unadjusted analysis, TAs (µg/g) was significantly higher in cases than controls, but not when expressed as TAs (µg/L). Cases had significantly lower urinary monomethylarsonic acid percentage (%MMA), first methylation ratio (FMR), creatinine, and choline and selenium intakes. In multi-adjusted models and in women without HTA history T2DM showed significant positive associations with %iAs and FMR, respectively, and a significant negative association with %DMA. In participants with HTA history there was a marginal positive association (p = 0.08) between T2DM and TAs concentrations (µg/g) without other significant associations. CONCLUSIONS: Our results support an association between T2DM prevalence and iAs metabolism but not with urinary arsenic levels. However, elucidation of the interplay among iAs metabolism, T2DM and HTA merit further studies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arsênio / Arsenicais / Diabetes Mellitus Tipo 2 Tipo de estudo: Health_technology_assessment / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Female / Humans País/Região como assunto: Mexico Idioma: En Revista: Environ Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arsênio / Arsenicais / Diabetes Mellitus Tipo 2 Tipo de estudo: Health_technology_assessment / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Female / Humans País/Região como assunto: Mexico Idioma: En Revista: Environ Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México